Symbols / MDCX Stock $0.31 -5.18% Medicus Pharma Ltd.

Healthcare • Drug Manufacturers - General • United States • NCM
MDCX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - General
CEO Dr. Raza Bokhari M.B.A., M.D.
Exch · Country NCM · United States
Market Cap 12.40M
Enterprise Value 9.27M
Income -47.28M
Sales —
FCF (ttm) -12.14M
Book/sh -0.00
Cash/sh 0.22
Employees 16
Insider 10d —
IPO Nov 14, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.78
PEG —
P/S —
P/B -104.97
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio 0.88
Current Ratio 0.99
Debt/Eq 14,679.33
LT Debt/Eq —
EPS (ttm) -2.74
EPS next Y -0.41
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-25
Earnings (prior) 2026-03-25
ROA -204.05%
ROE -29.81%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 39.36M
Shs Float 32.82M
Insider Own 18.47%
Instit Own 10.18%
Short Float 3.84%
Short Ratio 0.36
Short Interest 1.27M
52W High 8.94
vs 52W High -96.48%
52W Low 0.29
vs 52W Low 8.59%
Beta -0.04
Impl. Vol. —
Rel Volume 0.37
Avg Volume 6.15M
Volume 2.26M
Target (mean) $6.50
Tgt Median $7.50
Tgt Low $2.00
Tgt High $9.00
# Analysts 4
Recom Strong_buy
Prev Close $0.33
Price $0.31
Change -5.18%
About

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.50
Mean price target
2. Current target
$0.31
Latest analyst target
3. DCF / Fair value
$-5.55
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.31
Low
$2.00
High
$9.00
Mean
$6.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-20 main D. Boral Capital Buy → Buy $9
2026-03-19 main D. Boral Capital Buy → Buy $27
2026-03-09 main D. Boral Capital Buy → Buy $27
2025-12-15 main D. Boral Capital Buy → Buy $27
2025-11-17 main D. Boral Capital Buy → Buy $27
2025-11-13 main D. Boral Capital Buy → Buy $27
2025-10-29 main D. Boral Capital Buy → Buy $27
2025-10-22 main D. Boral Capital Buy → Buy $27
2025-10-14 main D. Boral Capital Buy → Buy $27
2025-09-29 main D. Boral Capital Buy → Buy $27
2025-09-02 main D. Boral Capital Buy → Buy $27
2025-08-22 main D. Boral Capital Buy → Buy $27
2025-08-13 main D. Boral Capital Buy → Buy $27
2025-07-09 main D. Boral Capital Buy → Buy $27
2025-07-01 main D. Boral Capital Buy → Buy $27
2025-06-23 main D. Boral Capital Buy → Buy $27
2025-06-09 main D. Boral Capital Buy → Buy $27
2025-05-29 main D. Boral Capital Buy → Buy $27
2025-05-22 main D. Boral Capital Buy → Buy $27
2025-05-12 main D. Boral Capital Buy → Buy $27
News
RSS: Latest MDCX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-08-13 QUINLAN JAMES P Chief Financial Officer — 145,000 $0.81 $156,250
2025-05-20 VELOCITY FUND PARTNERS, LP Beneficial Owner of more than 10% of a Class of Security — 75,000 $7.72 $578,940
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
34.36
+207.30%
11.18
+320.59%
2.66
+171.70%
0.98
Research And Development
16.44
+365.98%
3.53
+1722.41%
0.19
-70.05%
0.65
Selling General And Administration
17.92
+134.16%
7.65
+210.50%
2.46
+642.33%
0.33
General And Administrative Expense
17.92
+134.16%
7.65
+210.50%
2.46
+642.33%
0.33
Salaries And Wages
—
1.85
+664.92%
0.24
0.00
Other Gand A
17.92
+134.16%
7.65
+244.28%
2.22
+569.49%
0.33
Total Expenses
34.36
+207.30%
11.18
+320.59%
2.66
+171.70%
0.98
Operating Income
-34.36
-207.30%
-11.18
-320.59%
-2.66
-171.70%
-0.98
Total Operating Income As Reported
-34.36
-207.30%
-11.18
-136.39%
-4.73
-383.43%
-0.98
EBITDA
-34.36
-207.30%
-11.18
-320.59%
-2.66
-128.08%
-1.17
Normalized EBITDA
-33.47
-199.36%
-11.18
-1805.45%
-0.59
+62.24%
-1.55
EBIT
-34.36
-207.30%
-11.18
-320.59%
-2.66
-128.08%
-1.17
Total Unusual Items
-0.89
0.00
+100.00%
-2.07
-633.49%
0.39
Total Unusual Items Excluding Goodwill
-0.89
0.00
+100.00%
-2.07
-633.49%
0.39
Special Income Charges
-0.30
0.00
+100.00%
-2.07
-449.40%
0.59
Other Special Charges
0.30
—
2.07
+449.40%
-0.59
Net Income
-35.44
-217.73%
-11.16
-109.90%
-5.31
-214.04%
-1.69
Pretax Income
-35.44
-217.73%
-11.16
-109.90%
-5.31
-214.04%
-1.69
Net Non Operating Interest Income Expense
-0.20
-877.52%
0.03
+104.34%
-0.58
+46.94%
-1.10
Interest Expense Non Operating
—
0.90
+22.09%
0.74
+40.29%
0.53
Net Interest Income
-0.20
-877.52%
0.03
+104.34%
-0.58
+46.94%
-1.10
Interest Expense
—
0.90
+22.09%
0.74
+40.29%
0.53
Interest Income Non Operating
—
0.10
—
—
Interest Income
—
0.10
—
—
Other Income Expense
-0.89
-472.17%
0.24
+111.51%
-2.07
-633.49%
0.39
Other Non Operating Income Expenses
—
—
-3.27
—
Gain On Sale Of Security
-0.58
-344.77%
0.24
-64.41%
0.67
+427.53%
-0.20
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-35.44
-217.73%
-11.16
-109.90%
-5.31
-214.04%
-1.69
Net Income From Continuing Operation Net Minority Interest
-35.44
-217.73%
-11.16
-109.90%
-5.31
-214.04%
-1.69
Net Income From Continuing And Discontinued Operation
-35.44
-217.73%
-11.16
-109.90%
-5.31
-214.04%
-1.69
Net Income Continuous Operations
-35.44
-217.73%
-11.16
-109.90%
-5.31
-214.04%
-1.69
Minority Interests
0.00
0.00
—
—
Normalized Income
-34.56
-209.77%
-11.16
-243.97%
-3.24
-55.87%
-2.08
Net Income Common Stockholders
-47.28
-323.84%
-11.16
-109.90%
-5.31
-214.04%
-1.69
Diluted EPS
-2.74
-136.21%
-1.16
+24.18%
-1.53
-74.51%
-0.88
Basic EPS
-2.74
-136.21%
-1.16
+24.18%
-1.53
-74.51%
-0.88
Basic Average Shares
17.28
+79.68%
9.62
+176.45%
3.48
+80.26%
1.93
Diluted Average Shares
17.28
+79.68%
9.62
+176.45%
3.48
-56.77%
8.05
Diluted NI Availto Com Stockholders
-47.28
-323.84%
-11.16
-109.90%
-5.31
-214.04%
-1.69
Preferred Stock Dividends
11.84
—
—
—
Total Other Finance Cost
0.20
+877.52%
-0.03
-104.34%
0.58
+1.63%
0.58
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
10.06
+78.18%
5.65
+198.29%
1.89
+569.75%
0.28
Current Assets
9.89
+83.90%
5.38
+184.11%
1.89
+569.75%
0.28
Cash Cash Equivalents And Short Term Investments
8.71
+109.04%
4.16
+142.21%
1.72
+542.38%
0.27
Cash And Cash Equivalents
8.71
+109.04%
4.16
+142.21%
1.72
+542.38%
0.27
Cash Financial
—
—
1.72
+542.38%
0.27
Prepaid Assets
1.09
-10.53%
1.21
+598.82%
0.17
+1058.13%
0.01
Current Deferred Assets
0.10
0.00
—
—
Total Non Current Assets
0.17
-36.43%
0.27
0.00
0.00
Net PPE
0.17
-36.43%
0.27
0.00
—
Gross PPE
0.17
-36.43%
0.27
0.00
—
Other Properties
0.17
-36.43%
0.27
—
—
Total Liabilities Net Minority Interest
10.02
+299.02%
2.51
+221.41%
0.78
-93.74%
12.48
Current Liabilities
9.94
+330.92%
2.31
+195.06%
0.78
-93.74%
12.48
Payables And Accrued Expenses
4.25
+107.27%
2.05
+171.80%
0.75
+655.40%
0.10
Payables
3.55
+148.89%
1.43
+278.74%
0.38
—
Accounts Payable
3.44
+167.42%
1.28
+509.28%
0.21
—
Current Accrued Expenses
0.70
+11.78%
0.62
+64.92%
0.38
—
Pensionand Other Post Retirement Benefit Plans Current
0.30
+112.91%
0.14
+407.78%
0.03
—
Current Debt And Capital Lease Obligation
5.39
+4534.51%
0.12
—
1.53
Current Debt
5.25
—
—
1.53
Other Current Borrowings
—
—
—
1.38
Current Capital Lease Obligation
0.15
+25.04%
0.12
0.00
—
Other Current Liabilities
—
—
—
10.85
Total Non Current Liabilities Net Minority Interest
0.09
-58.24%
0.21
0.00
0.00
Long Term Debt And Capital Lease Obligation
0.09
-58.24%
0.21
0.00
—
Long Term Debt
0.03
—
—
—
Long Term Capital Lease Obligation
0.06
-70.80%
0.21
0.00
—
Stockholders Equity
-0.07
-102.16%
3.13
+182.04%
1.11
+109.11%
-12.20
Common Stock Equity
-0.07
-102.16%
3.13
+182.04%
1.11
+109.11%
-12.20
Capital Stock
57.39
+88.05%
30.52
+62.67%
18.76
+9544.00%
0.19
Common Stock
57.39
+88.05%
30.52
+62.67%
18.76
+9544.00%
0.19
Share Issued
25.18
+113.06%
11.82
+46.31%
8.08
+0.35%
8.05
Ordinary Shares Number
25.18
+113.06%
11.82
+46.31%
8.08
+0.35%
8.05
Additional Paid In Capital
6.88
+352.48%
1.52
+1442.23%
0.10
0.00
Retained Earnings
-64.35
-122.63%
-28.90
-62.85%
-17.75
-43.22%
-12.39
Gains Losses Not Affecting Retained Earnings
0.01
0.00
—
—
Minority Interest
0.10
0.00
—
—
Other Equity Adjustments
0.01
—
—
—
Total Equity Gross Minority Interest
0.04
-98.81%
3.13
+182.04%
1.11
+109.11%
-12.20
Total Capitalization
-0.04
-101.33%
3.13
+182.04%
1.11
+109.11%
-12.20
Working Capital
-0.05
-101.54%
3.07
+176.40%
1.11
+109.11%
-12.20
Invested Capital
5.20
+66.01%
3.13
+182.04%
1.11
+110.42%
-10.67
Total Debt
5.48
+1599.52%
0.32
0.00
-100.00%
1.53
Net Debt
—
—
—
1.26
Capital Lease Obligations
0.21
-36.20%
0.32
0.00
—
Net Tangible Assets
-0.07
-102.16%
3.13
+182.04%
1.11
+109.11%
-12.20
Tangible Book Value
-0.07
-102.16%
3.13
+182.04%
1.11
+109.11%
-12.20
Current Notes Payable
5.25
0.00
0.00
-100.00%
0.15
Dueto Related Parties Current
0.12
-18.24%
0.14
-14.16%
0.17
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-22.78
-122.27%
-10.25
-146.43%
-4.16
-293.36%
-1.06
Cash Flow From Continuing Operating Activities
-22.78
-122.27%
-10.25
-146.43%
-4.16
-293.36%
-1.06
Net Income From Continuing Operations
-35.44
-217.73%
-11.16
-109.90%
-5.31
-214.04%
-1.69
Other Non Cash Items
10.52
+6383.51%
0.16
-72.26%
0.58
-18.09%
0.71
Stock Based Compensation
1.51
+112.05%
0.71
+623.35%
0.10
0.00
Operating Gains Losses
0.07
—
—
—
Net Foreign Currency Exchange Gain Loss
0.04
0.00
—
—
Change In Working Capital
0.57
+1630.12%
0.03
-93.04%
0.47
+701.24%
-0.08
Change In Prepaid Assets
0.35
+133.92%
-1.04
-555.41%
-0.16
-958.13%
-0.01
Change In Payables And Accrued Expense
0.46
-59.87%
1.14
+80.95%
0.63
+1092.06%
-0.06
Change In Accrued Expense
-0.44
-222.56%
0.36
-7.44%
0.39
—
Change In Payable
0.90
+14.30%
0.79
+220.46%
0.25
—
Change In Account Payable
0.92
+14.20%
0.81
+922.59%
0.08
—
Change In Other Working Capital
-0.10
—
—
—
Change In Other Current Liabilities
-0.14
-103.50%
-0.07
0.00
—
Investing Cash Flow
-4.62
0.00
—
—
Cash Flow From Continuing Investing Activities
-4.62
0.00
—
—
Net Business Purchase And Sale
-4.62
0.00
—
—
Purchase Of Business
-4.62
0.00
—
—
Financing Cash Flow
31.94
+151.65%
12.69
+126.24%
5.61
+350.15%
1.25
Cash Flow From Continuing Financing Activities
31.94
+151.65%
12.69
+126.24%
5.61
+350.15%
1.25
Net Issuance Payments Of Debt
4.48
-13.48%
5.17
+934.50%
0.50
-59.88%
1.25
Issuance Of Debt
11.87
+129.41%
5.17
+934.50%
0.50
-59.88%
1.25
Repayment Of Debt
-7.39
0.00
—
—
Long Term Debt Issuance
11.87
+129.41%
5.17
+934.50%
0.50
-54.39%
1.10
Long Term Debt Payments
-7.39
0.00
—
—
Net Long Term Debt Issuance
4.48
-13.48%
5.17
+934.50%
0.50
-54.39%
1.10
Short Term Debt Issuance
—
—
0.00
-100.00%
0.15
Net Short Term Debt Issuance
—
—
0.00
-100.00%
0.15
Net Common Stock Issuance
18.22
+142.26%
7.52
0.00
—
Proceeds From Stock Option Exercised
10.04
0.00
—
—
Net Other Financing Charges
-0.79
—
5.11
—
Changes In Cash
4.54
+85.84%
2.44
+68.42%
1.45
+667.53%
0.19
Effect Of Exchange Rate Changes
-0.00
0.00
—
—
Beginning Cash Position
4.16
+142.21%
1.72
+542.38%
0.27
+240.90%
0.08
End Cash Position
8.71
+109.04%
4.16
+142.21%
1.72
+542.38%
0.27
Free Cash Flow
-22.78
-122.27%
-10.25
-146.43%
-4.16
-293.36%
-1.06
Interest Paid Supplemental Data
0.22
+446.47%
0.04
0.00
—
Common Stock Issuance
18.22
+142.26%
7.52
0.00
—
Issuance Of Capital Stock
18.22
+142.26%
7.52
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category